Alternatives to immediate release tacrolimus in solid organ transplant recipients: When the gold standard is in short supply-Reference-Cited by-同舟云学术

Alternatives to immediate release tacrolimus in solid organ transplant recipients: When the gold standard is in short supply

Published:2020-05-29 Issue:7 Volume:34 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Jorgenson Margaret R.¹^ORCID,Descourouez Jillian L.¹^ORCID,Brady Bethany L.²,Bowman Lyndsey³,Hammad Sara⁴,Kaiser Tiffany E.⁵,Laub Melissa R.⁶^ORCID,Melaragno Jennifer I.⁷,Park Jeong M.⁸,Chandran Mary M.⁹

Affiliation:

1. Department of Pharmacy University of Wisconsin Hospital and Clinics Madison WI USA

2. Pharmacy Department Indiana University Health University Hospital Indianapolis IN USA

3. Department of Pharmacy Tampa General Hospital Tampa FL USA

4. Department of Pharmacy University of Maryland Medical Center Baltimore MD USA

5. Department of Pharmacy University of Cincinnati Medical Center Cincinnati OH USA

6. Department of Pharmacy Augusta University Medical Center Augusta GA USA

7. Department of Pharmacy University of Rochester Medical Center Rochester NY USA

8. Department of Clinical Pharmacy University of Michigan College of Pharmacy Ann Arbor MI USA

9. Department of Pharmacy Children's Hospital of Colorado Aurora CO USA

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.13903

Reference110 articles.

1. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

2. Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant

3. FDA.Drug shortages.2019. Accessed athttps://www.accessdata.fda.gov/scripts/drugshortages/default.cfm. Accessed September 19 2019

4. Astagraf XL®[package insert].Northbrook IL:Astellas Pharma US Inc.;2015.

5. Envarsus XR®[package insert].Edison NJ:Veloxis Pharmaceuticals Inc;2018.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three-year outcomes of de novo tacrolimus extended-release tablets (LCPT) compared to twice-daily tacrolimus in adult heart transplantation;Transplant Immunology;2024-04

2. Review of two immunosuppressants: tacrolimus and cyclosporine;Journal of the Korean Association of Oral and Maxillofacial Surgeons;2023-12-31

3. Extended‐release tacrolimus dosing and outcomes in pediatric and young adult transplant recipients – A single‐center experience;Pediatric Transplantation;2023-09-21

4. Current advances in colloidal based delivery systems for Tacrolimus;Journal of Drug Delivery Science and Technology;2022-02

5. Effect of MMF Immunosuppression Based on CNI Reduction on CNI-Related Renal Damage after Lung Transplantation;Journal of Healthcare Engineering;2022-01-25